Epizyme Inc. Asset Turnover Ratio (EPZM), as of second quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Epizyme Inc.  (NASDAQ: EPZM)
 

Epizyme Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Epizyme Inc. asset turnover ratio, the ability of Epizyme Inc.'s assets to generate revenue in the second quarter 2022, increased sequentially to 0.19 in the second quarter (Jun 30 2022), yet the ratio remained below the average, as EPZM's position remain challenging.

Within sector 88 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2022 compared to previous quarter at no. 1725.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EPZM Asset Turnover Ratio (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Asset Change -27 % -24.68 % -40.73 % -13.79 % -17.05 %
Y / Y Revenue Change 111.59 % 13.96 % 38.33 % 45.85 % 427.36 %
Asset Turnover Ratio (TTM) 0.19 0.13 0.11 0.09 0.08
EPZM's Total Ranking # 1725 # 1725 # 2643 # 1721 # 2037
Seq. Asset Change -15.99 % 9.01 % -13.66 % -7.68 % -13.32 %
Seq. Revenue Change 216.56 % -24.94 % 122.75 % -60.02 % 70.49 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 89
Healthcare Sector # 203
Overall Market # 1725

Asset Turnover Ratio Statistics
High Average Low
17.17 6.84 2
(March 31, 2015)   (Sep 30 2019)




EPZM Company Profile • Back to EPZM Efficiency Comparisons • Compare EPZM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2022 Assets at quarter ending Jun 30 2022
Organon and Co   0.59 $ 6,355.000  Millions$ 10,806.750  Millions
Vapotherm Inc   0.59 $ 94.952  Millions$ 161.647  Millions
Exelixis Inc   0.59 $ 1,554.970  Millions$ 2,649.876  Millions
Evolus Inc   0.59 $ 132.405  Millions$ 226.071  Millions
Tela Bio Inc   0.58 $ 34.665  Millions$ 59.510  Millions
Lensar Inc   0.58 $ 36.872  Millions$ 63.391  Millions
Lannett Company Inc  0.58 $ 340.579  Millions$ 585.637  Millions
Zoetis Inc   0.58 $ 7,995.000  Millions$ 13,808.750  Millions
Iqvia Holdings Inc   0.58 $ 14,136.000  Millions$ 24,526.000  Millions
Sharecare Inc   0.58 $ 429.280  Millions$ 744.809  Millions
Optinose Inc   0.57 $ 79.677  Millions$ 138.659  Millions
Insulet Corporation  0.57 $ 1,178.100  Millions$ 2,057.650  Millions
Angiodynamics Inc   0.57 $ 316.219  Millions$ 553.283  Millions
Avantor Inc   0.57 $ 7,602.800  Millions$ 13,340.925  Millions
Airsculpt Technologies Inc   0.57 $ 89.198  Millions$ 156.640  Millions
Emergent Biosolutions Inc   0.57 $ 1,612.100  Millions$ 2,835.575  Millions
Caredx Inc   0.57 $ 314.859  Millions$ 554.448  Millions
Conmed Corporation  0.57 $ 1,042.314  Millions$ 1,844.523  Millions
Rigel Pharmaceuticals Inc  0.56 $ 88.506  Millions$ 157.730  Millions
Haemonetics Corporation  0.56 $ 1,025.237  Millions$ 1,828.283  Millions
Therapeuticsmd Inc   0.56 $ 91.978  Millions$ 164.671  Millions
Regeneron Pharmaceuticals Inc   0.55 $ 14,226.800  Millions$ 25,665.200  Millions
Pfizer Inc  0.55 $ 101,132.000  Millions$ 184,948.750  Millions
Icu Medical Inc  0.55 $ 1,780.711  Millions$ 3,264.204  Millions
Seaspine Holdings Corporation  0.55 $ 209.045  Millions$ 383.312  Millions
Societal Cdmo Inc   0.54 $ 84.886  Millions$ 155.814  Millions
Nuvasive Inc  0.54 $ 1,174.124  Millions$ 2,155.699  Millions
Neogen Corporation  0.54 $ 527.159  Millions$ 968.544  Millions
Lemaitre Vascular Inc   0.54 $ 159.540  Millions$ 293.538  Millions
Akebia Therapeutics Inc   0.54 $ 296.819  Millions$ 546.244  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.